Category: Insights

Unapproved Drugs: Opportunities for Rapid Approval and Market Exclusivity

Contrary to popular belief, there are many unapproved drugs which are actively being used. Many physicians may not even realize that that the drugs they are prescribing have not been…
The post Unapproved Drugs: Opportunities for Rapid Approval an…


Strategies for Pharmaceutical Companies to Boost Their Exports

Changes in the pharmaceutical sales model have forced leaders to invest in new selling strategies in recent years. However most of these New Commercial Models (NCMs) have not produced enough…
The post Strategies for Pharmaceutical Companies to Bo…


Patent Protection Strategies

This article was originally published by Himanshu Gupta, Suresh Kumar, Saroj Kumar Roy, and R. S. Gaud at J Pharm Bioallied Sci. 2010 Jan-Mar; 2(1): 2–7. Abstract It is widely recognized…
The post Patent Protection Strategies appeared first on Dr…


Factors that influence the development of generic drugs in the US

The trillion dollar pharmaceutical sector has been dominated for long by a few giant firms that manufacture and supply the major branded prescription drugs. However, recent trends point to the…
The post Factors that influence the development of g…


Re-Thinking Management Strategies for Specialty Drug Cost Containment

A 2016 report by the Kaiser Family Foundation reported that approximately one-quarter of the people in the United States have difficulty affording their medications. For low-income individuals, the cost of…
The post Re-Thinking Management Strateg…


Leveraging affordable innovation to tackle India’s healthcare challenge

This article was originally published by Kiran Mazumdar Shaw in IIMB Management Review under a Creative Commons license. Abstract Affordable innovation, which presents ways to innovate, be flexible, and do more with…
The post Leveraging affordabl…


A Comparison of Generic Drug Prices in Seven European Countries: A Methodological Analysis

This paper was originally published by Olivier J. Wouters and Panos G. Kanavos in BMC Health Services Research  2017 17:242 https://doi.org/10.1186/s12913-017-2184-5 ©  The Author(s). 2017 Abstract Background Policymakers and researchers frequently com…


Rising Pharmaceutical Costs a Major Challenge for Managed Healthcare

The steep rise in pharmaceutical prices year over year is old news at this point. Even a number of generic drugs are going up in price, causing difficulties for insurers…
The post Rising Pharmaceutical Costs a Major Challenge for Managed Healthca…


Should Price or Product Be the Determinant in Pharmaceutical Competition?

Pharmaceutical competition incorporates different tactics in different markets because countries have divergent approaches to regulating healthcare costs. Both price and product have roles in defining the competitive landscape in pharmaceuticals,&#8230…


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: